PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Cytacon 50microgram tablets
0901020D0BCAAAE
Cytacon Cyanocobalamin Nutrition and Blood No data available
Cytafoam dressing 10cm x 10cm
20030900474
Cytafoam dressing 10cm x 10cm Wound Management & Other Dressings Dressings No data available
Cytafoam dressing 15cm x 15cm
20030900475
Cytafoam dressing 15cm x 15cm Wound Management & Other Dressings Dressings No data available
Cytafoam dressing 17cm x 17.5cm sacral
20030900476
Cytafoam dressing 17cm x 17.5cm sacral Wound Management & Other Dressings Dressings No data available
Cytafoam dressing 23cm x 23cm sacral
20030900477
Cytafoam dressing 23cm x 23cm sacral Wound Management & Other Dressings Dressings No data available
Cytafoam dressing 5cm x 5cm
20030900473
Cytafoam dressing 5cm x 5cm Wound Management & Other Dressings Dressings No data available
Cytarabine (liposomal) 50mg/5ml inj vials
0801030D0AAANAN
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 100mg/1ml solution for injection vials
0801030D0AAAHAH
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 100mg/5ml solution for injection Cytosafe vials
0801030D0BFAAAI
Cytarabine (Cytosafe) Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 100mg/5ml solution for injection vials
0801030D0AAAIAI
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 1g/10ml solution for injection Cytosafe vials
0801030D0BFACAK
Cytarabine (Cytosafe) Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 1g/10ml solution for injection vials
0801030D0AAAKAK
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 2g/20ml solution for injection Cytosafe vials
0801030D0BFADAL
Cytarabine (Cytosafe) Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 2g/20ml solution for injection vials
0801030D0AAALAL
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 4g/40ml solution for injection vials
0801030D0AAAPAP
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 500mg/25ml solution for injection Cytosafe vials
0801030D0BFABAM
Cytarabine (Cytosafe) Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 500mg/25ml solution for injection vials
0801030D0AAAMAM
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 500mg/5ml solution for injection vials
0801030D0AAAJAJ
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytarabine 5g/50ml solution for infusion vials
0801030D0AAAQAQ
Cytarabine Cytarabine Malignant Disease and Immunosuppression No data available
Cytasorb dressing 10cm x 10cm square
20030000003
Cytasorb dressing 10cm x 10cm square Wound Management & Other Dressings Dressings No data available
Cytasorb dressing 15cm x 15cm square
20030000004
Cytasorb dressing 15cm x 15cm square Wound Management & Other Dressings Dressings No data available
Cytasorb dressing 20cm x 30cm rectangular
20030000006
Cytasorb dressing 20cm x 30cm rectangular Wound Management & Other Dressings Dressings No data available
Cytasorb dressing 20cm x 40cm rectangular
20030000007
Cytasorb dressing 20cm x 40cm rectangular Wound Management & Other Dressings Dressings No data available
Cytoplan Fish Oil High Potency 1000mg capsules
091200000BFUJA0
Proprietary compound preparation BNF 0912000 Other health supplement preparations Nutrition and Blood No data available
Cytoplan Glucosamine hydrochloride 750mg capsules
1001050A0CDAAAM
Cytoplan (Glucosamine hydrochloride) Glucosamine hydrochloride (Rheumatic) Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.